← back to search

Martin Gunnarsson

Örebro University · SE
Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Polyomavirus and related diseases, and Amyotrophic Lateral Sclerosis Research.
h-index
24
citations
4,153
works
78
NIH funding
primary concept
email

Recent publications

<scp>COMBAT</scp>‐<scp>MS</scp>: A Population‐Based Observational Cohort Study Addressing the Benefit–Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab
Annals of Neurology 2024cited by 19position: middledoi
Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage
Journal of Neurology Neurosurgery & Psychiatry 2023cited by 13position: middledoi
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial
The Lancet Neurology 2022cited by 122position: middledoi
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study
European Journal of Neurology 2021cited by 54position: middledoi
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
Annals of Neurology 2020cited by 134position: middledoi
Epstein–Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis
European Journal of Neurology 2020cited by 54position: middledoi
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
JAMA Neurology 2019cited by 750position: middledoi
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
JAMA Neurology 2019cited by 503position: middledoi
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
Neurology 2017cited by 423position: middledoi
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society
Acta Neurologica Scandinavica 2016cited by 74position: middledoi
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
Journal of Neurology Neurosurgery & Psychiatry 2014cited by 166position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Anders Svenningsson · Karolinska University Hospital7 papers (2014–2024)Tomas Olsson · Karolinska University Hospital7 papers (2017–2024) · 7 papers (2014–2023)Jan Lycke · Sahlgrenska University Hospital6 papers (2014–2022)Joachim Burman · Aarhus University6 papers (2014–2024)Fredrik Piehl · Karolinska University Hospital6 papers (2016–2024)Anna Fogdell‐Hahn · Affibody (Sweden)5 papers (2019–2024)Peter Ström · University of Pittsburgh5 papers (2017–2023) · 5 papers (2019–2024)Katharina Fink · Karolinska University Hospital4 papers (2019–2024)Thomas Frisell · Karolinska Institutet4 papers (2019–2024)Petra Nilsson · Lund University4 papers (2014–2020) · 3 papers (2020–2023)Nicole Brenner · German Cancer Research Center3 papers (2020–2023)Markus Axelsson · Linköping University3 papers (2016–2022)Julia Butt · German Cancer Research Center3 papers (2020–2023) · 3 papers (2020–2023) · 3 papers (2020–2023)Jan Hillert · Karolinska University Hospital3 papers (2019–2024)Peter Alping · Karolinska Institutet3 papers (2019–2024)